These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 24342762)
1. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry). Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762 [TBL] [Abstract][Full Text] [Related]
2. Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Natsuaki M; Furukawa Y; Morimoto T; Sakata R; Kimura T; Am J Cardiol; 2012 Dec; 110(11):1568-77. PubMed ID: 22935527 [TBL] [Abstract][Full Text] [Related]
3. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents. Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536 [TBL] [Abstract][Full Text] [Related]
4. Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease. Resmini C; Di Cuia M; Ballocca F; D'Ascenzo F; Bollati M; Moretti C; Omedè PL; Sciuto F; Gaita F; Sheiban I Minerva Cardioangiol; 2012 Dec; 60(6):573-80. PubMed ID: 23147435 [TBL] [Abstract][Full Text] [Related]
5. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. Latif F; Kleiman NS; Cohen DJ; Pencina MJ; Yen CH; Cutlip DE; Moliterno DJ; Nassif D; Lopez JJ; Saucedo JF; JACC Cardiovasc Interv; 2009 Jan; 2(1):37-45. PubMed ID: 19463396 [TBL] [Abstract][Full Text] [Related]
6. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244 [TBL] [Abstract][Full Text] [Related]
7. β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure. Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tazaki J; Natsuaki M; Kimura T; Int J Cardiol; 2013 Sep; 168(2):774-9. PubMed ID: 23127614 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706 [TBL] [Abstract][Full Text] [Related]
9. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry. Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993 [TBL] [Abstract][Full Text] [Related]
11. Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention. Mangiacapra F; Cavallari I; Barbato E; Ricottini E; Patti G; Vizzi V; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G Am J Cardiol; 2014 Apr; 113(7):1124-9. PubMed ID: 24507863 [TBL] [Abstract][Full Text] [Related]
12. Preprocedural statin use in patients undergoing percutaneous coronary intervention. Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS; Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867 [TBL] [Abstract][Full Text] [Related]
13. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry. Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF; Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166 [TBL] [Abstract][Full Text] [Related]
14. The impact of age and chronic kidney disease on secondary prevention post-primary percutaneous coronary intervention. Zachariah D; Brown R; Kanagala P; Bashir A; Mohan M; Callan P; Rajendra R; Clark AL; Squire I; Gunning M; Lang CC; Kalra PR QJM; 2014 Mar; 107(3):185-92. PubMed ID: 24194563 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ; Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057 [TBL] [Abstract][Full Text] [Related]
16. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes. Tentzeris I; Rohla M; Jarai R; Farhan S; Freynhofer MK; Unger G; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K Am J Cardiol; 2014 Apr; 113(7):1099-104. PubMed ID: 24462073 [TBL] [Abstract][Full Text] [Related]
17. Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era. Midwall S; Swaminathan RV; Charitakis K; Kim LK; Gordin J; Hriljac I; Minutello RM; Bergman G; Wong SC; Feldman DN J Invasive Cardiol; 2013 Mar; 25(3):132-6. PubMed ID: 23468442 [TBL] [Abstract][Full Text] [Related]
18. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Bae EH; Lim SY; Cho KH; Choi JS; Kim CS; Park JW; Ma SK; Jeong MH; Kim SW Am J Kidney Dis; 2012 Jun; 59(6):795-802. PubMed ID: 22445708 [TBL] [Abstract][Full Text] [Related]
19. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). Cheng JM; Onuma Y; Piazza N; Nuis RJ; Van Domburg RT; Serruys PW; Am J Cardiol; 2010 Nov; 106(10):1376-81. PubMed ID: 21059424 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry. Baber U; Mehran R; Kirtane AJ; Gurbel PA; Christodoulidis G; Maehara A; Witzenbichler B; Weisz G; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Xu K; Parise H; Brodie BR; Stuckey TD; Stone GW Circ Cardiovasc Interv; 2015 Jun; 8(6):e001683. PubMed ID: 26056248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]